Foster Dykema Cabot & Co’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $497K | Buy |
3,332
+83
| +3% | +$12.2K | 0.06% | 56 |
|
|
2023
Q2 | $438K | Sell |
3,249
-32
| -1% | -$4.69K | 0.05% | 60 |
|
|
2023
Q1 | $523K | Buy |
3,281
+250
| +8% | +$38.2K | 0.07% | 56 |
|
|
2022
Q4 | $490K | Sell |
3,031
-410
| -12% | -$62.9K | 0.07% | 51 |
|
|
2022
Q3 | $462K | Hold |
3,441
| – | – | 0.06% | 56 |
|
|
2022
Q2 | $527K | Sell |
3,441
-80
| -2% | -$12.2K | 0.07% | 52 |
|
|
2022
Q1 | $571K | Sell |
3,521
-155
| -4% | -$22.5K | 0.07% | 58 |
|
|
2021
Q4 | $498K | Hold |
3,676
| – | – | 0.06% | 66 |
|
|
2021
Q3 | $397K | Sell |
3,676
-304
| -8% | -$34.7K | 0.05% | 72 |
|
|
2021
Q2 | $448K | Sell |
3,980
-418
| -10% | -$47.1K | 0.06% | 66 |
|
|
2021
Q1 | $476K | Sell |
4,398
-322
| -7% | -$34.4K | 0.06% | 62 |
|
|
2020
Q4 | $506K | Sell |
4,720
-1,044
| -18% | -$100K | 0.07% | 65 |
|
|
2020
Q3 | $505K | Sell |
5,764
-106
| -2% | -$9.98K | 0.08% | 63 |
|
|
2020
Q2 | $576K | Buy |
5,870
+68
| +1% | +$5.99K | 0.1% | 57 |
|
|
2020
Q1 | $442K | Hold |
5,802
| – | – | 0.09% | 54 |
|
|
2019
Q4 | $514K | Hold |
5,802
| – | – | 0.07% | 68 |
|
|
2019
Q3 | $439K | Hold |
5,802
| – | – | 0.06% | 77 |
|
|
2019
Q2 | $422K | Sell |
5,802
-26
| -0.4% | -$2.04K | 0.06% | 78 |
|
|
2019
Q1 | $470K | Sell |
5,828
-135
| -2% | -$11K | 0.08% | 71 |
|
|
2018
Q4 | $550K | Hold |
5,963
| – | – | 0.1% | 59 |
|
|
2018
Q3 | $564K | Sell |
5,963
-27
| -0.5% | -$2.56K | 0.09% | 65 |
|
|
2018
Q2 | $548K | Sell |
5,990
-52
| -0.9% | -$5.08K | 0.09% | 66 |
|
|
2018
Q1 | $572K | Hold |
6,042
| – | – | 0.1% | 68 |
|
|
2017
Q4 | $584K | Sell |
6,042
-410
| -6% | -$38.6K | 0.1% | 67 |
|
|
2017
Q3 | $573K | Hold |
6,452
| – | – | 0.1% | 62 |
|
|
2017
Q2 | $468K | Sell |
6,452
-360
| -5% | -$24.2K | 0.08% | 76 |
|
|
2017
Q1 | $444K | Hold |
6,812
| – | – | 0.08% | 76 |
|
|
2016
Q4 | $427K | Hold |
6,812
| – | – | 0.08% | 77 |
|
|
2016
Q3 | $430K | Sell |
6,812
-720
| -10% | -$46.6K | 0.09% | 79 |
|
|
2016
Q2 | $466K | Sell |
7,532
-680
| -8% | -$41.4K | 0.11% | 69 |
|
|
2016
Q1 | $469K | Hold |
8,212
| – | – | 0.11% | 63 |
|
|
2015
Q4 | $486K | Buy |
+8,212
| New | +$473K | 0.12% | 63 |
|
|
2015
Q3 | – | Sell |
-3,277
| Closed | -$220K | – | 88 |
|
|
2015
Q2 | $220K | Buy |
+3,277
| New | +$214K | 0.06% | 84 |
|
|
2015
Q1 | – | Sell |
-3,277
| Closed | -$214K | – | 89 |
|
|
2014
Q4 | $214K | Buy |
+3,277
| New | +$207K | 0.05% | 88 |
|
|
2013
Q4 | – | Sell |
-12,025
| Closed | -$538K | – | 92 |
|
|
2013
Q3 | $538K | Sell |
12,025
-610
| -5% | -$27K | 0.16% | 53 |
|
|
2013
Q2 | $522K | Buy |
+12,635
| New | +$553K | 0.16% | 54 |
|
Other funds holding ABBV
Foster Dykema Cabot & Co's ABBV Position: Q3 2023 in Review
Foster Dykema Cabot & Co increased its AbbVie (ABBV) stake by 2.6% in Q3 2023, buying an estimated $12.2K and bringing the position to 3,332 shares worth $497K. The position accounts for 0.06% of the portfolio, ranked #56.
Foster Dykema Cabot & Co first reported a position in ABBV in Q2 2013 and has held it in 36 quarters since. The position peaked at $584K in Q4 2017. 3,108 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.
- Foster Dykema Cabot & Co held 3,332 shares of AbbVie worth $497K as of Q3 2023.
- Foster Dykema Cabot & Co bought 83 AbbVie shares in Q3 2023, an estimated $12.2K.
- AbbVie made up 0.06% of Foster Dykema Cabot & Co's portfolio in Q3 2023, its #56 holding.
- Foster Dykema Cabot & Co first reported a position in AbbVie in Q2 2013 and has held it in 36 quarters since.
- Foster Dykema Cabot & Co's AbbVie position peaked at $584K in Q4 2017.
- 3,108 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.
Based on Foster Dykema Cabot & Co's 13F filing for Q3 2023, filed 14 Nov 2023.